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Copper as a metal chelator in ethambutol may interfere oxidative phosphorylation and 
mitochondrial function that are useful in the formation of ATP, so that long-term damage can cause 
apoptosis and interfere color vision. This study aims to determine the correlation between duration 
of ethambutol and copper levels in serum with color vision disorder examined with Farnsworth 
Munsell 100 Hue (FM100) in patients with tuberculosis. This study was an explorative observation 
of 20 samples during November 2017 - January 2018 period. Comparative analysis using 
independent t-test, paired t-test, Wilcoxon test and Mann-Whitney test, while correlation analysis 
using Spearman's test and Pearson's test. There was a significant difference of FM100value before 
and after in category I (p=0.000) with increase of total error value 11.80+5.31 or category II 
(p=0.000) with increase of total error value 15.00+7.41. There was significant difference of Cu2+  
level before and after in category I (p=0.005) with decrease of  Cu2+ level 15.57+5.04 mg/dL or 
category II (p=0.005) with decrease of  Cu2+ level 31.66+7.35 mg/dL. The duration of Ethambutol 
was related to changes in color vision examined with FM100. 
 





Tuberculosis is an important public 
health problem because one third of the 
world's population is infected by the 
Mycobacterium tuberculosis bacteria. The 
World Health Organization (WHO) in 
1993 declared tuberculosis a global 
concern that must be addressed jointly by 
all countries in the world. WHO also 
estimates that as many as 2-4 people are 
infected with TB every second, and 
nearly 4 people every minute die of TB. 
TB facts in Indonesia to date there are a 
quarter million cases and 140,000 deaths 
occur annually, and TB in Indonesia is 
the number one killer among infectious 
diseases and number three after heart 
disease and acute respiratory disease in 
all ages. Data taken from the Palembang 
City Health Profile in 2014 showed the 
number of pulmonary TB cases of 1972 
cases.1-5 
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In line with the increase in TB cases, 
in the early 1990s WHO and IUATLD 
developed a TB control strategy known as 
the DOTS (Directly Observed Treatment 
Short-course) strategy. The main focus of 
DOTS is the discovery and healing of 
patients, priority is given to infectious 
type TB patients. This strategy aims to 
break the chain of TB transmission and 
thereby reduce the incidence of TB in the 
community and prevent the development 
of MDR-TB (Multi Drugs Resistance-
TB). The treatment that isused by the 
National Program for TB Control by the 
Government of Indonesia using the 
DOTS strategy is the use of Anti 
Tuberculosis Drugs (OAT). Commonly 
used drugs are Isoniazid, Etambutol, 
Rifampicin, Pirazinamid, and 
Streptomycin. This group of drugs is 
referred to as primary or first-line drugs. 
3,4,6 
Ethambutol is one of the drugs used 
in the initial line of TB therapy, and its 
side effects in the form of optic 
neuropathy have been known since the 
first use of TB drugs in 1960.9 Optic 
neuropathy that occurs in the use of 
ethambutol depends on the dose and 
duration of use of ethambutol. Side effects 
caused by the use of ethambutol can occur 
in patients who have used the drug for at 
least 2 months, while symptoms generally 
appear between 4 months to one year. 
Kumar, reported that ethambutol toxicity 
occurred was 42.2% within 10-12 months 
after administration of ethambutol. Robert 
reported that administration of ethambutol 
15 mg / kg / day for 4-8 months of therapy 
can cause optic nuropathy in 1.6% of cases 
and if given at a dose of 25 mg / kg / day 
cause optic neuropathy in 2.48% of cases. 
4-5,7,8,9 
Ethambutol has a toxic effect on 
nerve fibers in the retinal ganglion. The 
onset of complaints in the eye is usually 
slow, can be months after starting therapy 
(on average between 3-5 months, some 
even up to 12 months), rarely appearing 
acutely. Affected patients will complain 
of a sharp decrease in vision in both eyes 
without pain, a decrease in contrast and 
color sensitivity and visual field 
disturbances. On inspectionphysically, 
the disturbance that occurs in both eyes is 
symmetrical. Discromatopsia (color 
perception abnormalities) is usually the 
earliest sign of toxicity, classically shown 
by a decrease in red-green color 
perception that is assessed using ishiara. 
Contrary to this, Polak et al reported that 
blue-yellow defects were the most 
common initial defects in patients without 
symptoms of visual impairment. But the 
blue-yellow defect can only be detected 
using the Lantony desaturation panel or 
using Farnsworth Munsell 100 hue 
(FM100), not using Ishihara. 8-14 
The toxicity that occurs in the use of 
ethambutol is still hypothetical. This 
hypothesis links toxicity to occur through 
oxidative phospholiration disorders so 
that metabolism in the mitochondria of 
Retinal Ganglion Cells (RGCs) is also 
disrupted. Mitochondria play an 
important role in the process of anaerobic 
respiration, which produces ATP as a 
source of cellular energy. The latest 
research conducted on the role of Cu in 
ethambutol toxicity found that Cu plays a 
role in ethambutol toxicity by triggering 
the occurrence of mitochondrial apoptosis 
in RGCs. 8-9,15-26Copper (Cu) is a metal 
called the "essential trace element" which 
is an important element in the growth and 
development of almost all 
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microorganisms, including bacteria. The 
function of Cu in the eye plays a role in 
maintaining vision. 26-29 As a metal 
chelator found in ethambutol, Cu can 
interfere with oxidative phospholiration 
and mitochondrial functions that are 
useful in the formation of ATP.  
Therefore,color vision disorders can 
also occur if there is a decrease in serum 
Cu levels in patients with pulmonary 
tuberculosis. In several studies conducted 
by Koyonagi et al, found serum Cu levels 
in patients using anti-tuberculosis drugs 
significantly decreased. Abdonasser et al 
reported that after 10 days of Ethambutol 
treatment, the level of Cu in pulmonary 
tuberculosis patients decreased 
significantly. They also state that these 
results support the hypothesis that 
Ethambutol with Cu can make complex 
chemical reactions in the body and cause 
changes in Cu concentration. 27-31 
Based on the above data it can be 
said if the use of ethambutol can reduce 
Cu levels which ultimately can cause 
color vision disorders.The purpose of this 
study was to determine the comparison of 
serum copper levels and color vision 
disorders in patients with active 
pulmonary tuberculosis before and after 
ethambutol administration of category I 





This study is a prospective study that 
aims to assess the comparison between 
serum levels of copper and color vision 
disorders in patients with pulmonary 
tuberculosis before and after 
administration of category I and category 
ethambutol. This research was conducted 
at Mohammad Hoesin Hospital 
Palembang and Merdeka Public Health 
Center. The entire implementation time 
starts from November 2017 to January 
2018. The target population is all 
pulmonary TB sufferers who seek 
treatment at the Internal Medicine Clinic 
of RSMH and Merdeka Public Health 
Center in Palembang.The sample 
selection method used is consecutive 
sampling.  
The inclusion criteria of this study 
were (a) all pulmonary TB patients who 
received category I and category II 
ethambutol therapy. (b) Willing to follow 
the stated research by signing an 
informed consent letter (c) Age between 
18-69 years. While the exclusion criteria 
are TB sufferers with congenital color 
blindness (b) Lung TB patients who are 
difficult to do the examination. Patients 
with toxic optic neuropathy for other 
reasons. (c) Patients who have anterior 
segment abnormalities. Patients who have 
posterior segment abnormalities. 
All data is displayed in the form of 
tabulated data and performed statistical 
analysis using a computer program with 
the SPSS program. For the general 
characteristics of research subjects, the 
normality test with Shapiro-Wilk will be 
used. Comparisons before and after the 
use of category I and category II use the 
paired t test (parametic) and the Mann-
Whitney test (nonparametric). Correlation 
in this research will be analyzed using 
Pearson test (parametric) and Spearman 
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General characteristics of research 
subjects are presented in Table 4.1 below. 
 
Table 1. General Characteristics of Research 
Subjects 
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Basic vision OS 
<0.5 


































0 -2 month 
>2 – 4 months 









PNS: Pegawai Negeri Sipil; BMI: Body Mass Index 
 
Based on the non-parametric 
comparison test using the Mann-Whitney 
test, the results showed that there were no 
statistically significant differences in Cu 
levels before Ethambutol therapy in the 
category I and category II with a p value 
= 0.075. While, based on the non-
parametric comparison test using the 
Mann-Whitney test, the results showed 
that there was a statistically significant 
difference in Cu levels after between the 
category I and category II groups with a 
value of p = 0,000 
 
Table.2 Comparison of Cu levels before and after 
in category I and II  










*Mann-Whitney Test (p<0.05)  
**Paired T Test (p<0.05)  
 
In the category 1 group, it was 
found that changes in Cu before and after 
were equal to 15.57 ± 5.04 μg / dL. Based 
on the analysis of the Wilcoxon test the 
results show that there are statistically 
significant differences in Cu levels before 
and after in category I with a value of p = 
0.005. In the category II, it was found that 
changes in Cu levels before and after 
ethambutol therapy were 31.66 ± 7.35 μg 
/ dL. Based on the analysis of the 
Wilcoxon test it was found that there 
were statistically significant differences 
in Cu levels before and after ethambutol 
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Table. 3 Comparison of Cu levels in Category I 
and II 
 Cu Before Cu After Difference p*** 










***Wilcoxon Test (p<0.05) 
 
In this study the results showed 
that the results of FM100 examination 
before ethambutol therapy in category I 
were 11.30 ± 3.89 while in category 2 it 
was 24.40 ± 6.72. Based on the 
parametric comparison test using the 
unpaired T test shows that there are 
results a statistically significant difference 
before the FM100 examination results 
between the category I and category II 
groups with a value of p = 0,000. 
 
Table 4. Comparison of the results of the FM100 
before and after in categories I and II 
**Paired T Test (p<0.05) 
 
In the category I group, there was 
an increase in the total error value before 
and after, which was 11.80 ± 5.31. Based 
on the analysis of paired T test results 
obtained that there are significant 
differencesof FM100 examination results 
before and after in category I with a value 
of p = 0,000.In the category II group, an 
increase in the total error value before and 
after was equal to 15.00 ±7.41. Based on 
the analysis of the paired T test results 
showed that there were statistically 
significant differences in the results of the 
FM100 examination before and after in 
category II with a value of p = 0,000. 
 

























The distribution of the subjects of this 
study was based on gender, that is not 
found differences, male and female 10 
subjects each (50%). The results of this 
study differed from the findings of Nazari 
et al in 2009 that were 26 subjects 
(43.3%) female and 34 subjects (56.7%) 
male. Reyes et al in 2013 in the 
Philippines also found that 105 subjects 
were male by 73.3% .28-29 
The findings of this study that there 
are no differences in sex might be 
influenced by several factors. Men can be 
considered more susceptible to 
mycobacterial tuberculosis microbial 
exposure not only by biological function 
but also due to higher mobility and 
activity than women. Can also be caused 
by the impact of risk factors from 
exposure such as smoking, employment, 
industrial exposure and others. 
Vulnerability of men to tuberculosis 
exposure is not only happening in 
 p** FM100 After p** 
Category 
I 
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Indonesia. According to data from the 
World Health Organization (WHO), other 
Southeast Asian countries also have the 
same case, namely pulmonary 
tuberculosis is more experienced by men. 
According to WHO data in Thailand, in 
2006 had 29,081 new cases of positive 
tuberculosis with 70% were 
male.Likewise, in Myanmar, 66% of 
people with tuberculosis in the country 
are male.3,4 
Other studies in several developing 
countries say that tuberculosis patients 
suffer more women than men. Because 
most of the population are poor families, 
while the fact is that in the process of 
cooking food, many women are exposed 
to smoke from firewood or biogas (cow 
dung which is burned as fuel in the room. 
Due to the dominant role in the 
household, poor women often dwell in 
homes with poor lighting and ventilation. 
3,4 
The most subjects in this study were 
the age group of 30-39 years, with 10 
subjects (50%), while the least age group 
was 60-69 years, amounting to 1 person 
(5%). The age of the oldest study subjects 
was 62 years and the youngest at the age 
of 24 years and the average age of the 
study subjects was 36.35 years. The 
results of this study are consistent with 
the research of Reyes et al who examined 
the research subjects at the age of 16-68 
years with an average age of 37.1 years. 
Research Cruz et al also showed the 
average age of the study subjects was 
38.67 years. This shows that pulmonary 
tuberculosis is more common in adult 
patients. So, based on the age of 
tuberculosis patients, the rate of 
transmission of this disease is higher in 
the productive age because it interacts 
more frequently with the surrounding 
environment.8,14,15,17,28 
The distribution of the education level 
of the subjects of this study is 1 subject 
(5%), 9 subjects (45%) high school, 8 
subjects (40%) and 2 subjects (10%) of 
elementary school. These results are in 
accordance with the research of Karyadi 
et al. WHO states that pulmonary 
tuberculosis not only attacks people at 
productive age, but also attacks people 
with low education. This is because the 
level of education influences the level of 
public knowledge on information about 
fulfilling balanced nutrition and the 
prevention and treatment of pulmonary 
tuberculosis. Other studies by Suswati 
showed that there was no relationship 
between education levels in tuberculosis 
patients. 
In this study, the most types of work 
were private employees, namely 10 
subjects (50%) while 1 subject (5%) who 
did not work and 3 subjects (15%) 
became housewives. The same thing in 
the study of Karyadi et al found that the 
type of work the subject of research was 
private workers by 23 people (40%). The 
type of work a person influences on 
family income. Because family income 
will have an impact on the quality and 
patterns of daily living including 
consumption of nutritious food and health 
care. In this study as many as 12 subjects 
(60%) had underweight nutritional status 
while 8 other subjects (40%) had 
normoweight nutritional status. These 
results are consistent with the findings of 
the study of Karyadi et al in 2000 to get 
patients with underweight IMT as many 
as 57 (63.3%). Then Karyadi et al 
continued research in 2002 and obtained 
underweight research subjects of 51 
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people (63.7%). Research Cruz et al 
showed the results of underweight 
subjects as many as 41 people (64.1%), 
followed by normoweight of 19 people 
(29.6%) and overweight in 4 people 
(6.3%). Nutritional status is one of the 
factors that influences the development of 
active pulmonary tuberculosis which 
experiences weight loss and decreased 
appetite. Also followed, in developing 
countries where the population is still 
poor, there is a lack of micronutrient 
intake.14.29 
Examination of subjects with Snellen 
Chart converted to LogMAR and 
obtained 15 subjects (75%) for the right 
eye and 17 subjects (85%) for the left eye 
had <0.5, while 5 subjects (25%) with 
refractive anomalies having sharp basic 
vision of 0.5-1.0.All subjects were 
screened for color vision screening before 
and after the use of category I and 
category II Ethambutol with Ishihara and 
normal results were obtained. Where this 
examination is cheaper and easier to 
interpret. Usually this tool is also used to 
detect congenital color vision 
abnormalities and red-green color vision 
disorders. This tool has a deficiency in 
assessing disturbances in assessing visual 
impairment in blue and yellow. Ishihara 
can also assess protan defects in color 
vision but this tool is not ideal for 
assessing tritan defects that occur in the 
use of ethambutol, so we need to use the 
Farnsworth Munsell 100 Hue tool to 
detect color disturbances that occur in 
pulmonary TB patients using 
ethambutol.8, 31-35 
Examination with Farnsworth Munsel 
100 Hue is the gold standard for checking 
color vision because it is more sensitive 
and can analyze quantitatively. In the 
study subjects, the results of the 
assessment of superior color vision were 
12 subjects (60%) and average color 
vision in 8 subjects (40%). Examination 
disorders are divided into visual 
disturbances in red and green and blue-
yellow in vision. Red-green color vision 
impairment in 2 people and blue and 
yellow color vision disorder in 8 people. 
Based on Mira Tetiana's research, the 
examination of all research subjects 
obtained normal ishihara examination, 
while the Farnsworth Munsell 100 Hue 
examination found 16 people (44.4%) 
there was a moderate error value. Tetiana 
Mira, Azri Wahyuni Devi, Saleh Irsan, 
Rasyid Ahmad categorized the visual 
impairment of red-green as much as 8.3% 
and 44.4% of the blue-yellow visual 
impairment. Based on research Kaimbo et 
al said that the disorder blue-yellow color 
vision is an early symptom of ethambutol 
intoxication, while red-green color vision 
disorder is a symptom that can be found 
afterwards. Changes in color can occur 
despite the sharp vision of normal 
patients. Color vision disturbance is an 
early sensitive indicator of optic 
neuropathy symptoms due to 
ethambutol.8,9,12,13 
The distribution of research subjects 
based on the length of use of ethambutol 
obtained as many as 10 subjects (50%) 
using ethambutol for 0-2 months and as 
many as 7 subjects (35%) using 
ethambutol for> 4 months. Color vision 
disorders can occur in a few weeks after 
using ethambutol, but some also occur 
after 5 months of therapy. Therefore, in 
this study the duration of use of 
ethambutol was divided into 3 groups 
namely 0-2 months, groups 2-4 months 
and> 4 months.8,17 
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In this study, subjects in category 1 
groups were obtainedexperiencing 
changes in Cu levels before and after 
namely a decrease of 15.57 ± 5.04 μg / 
dL. Based on the analysis of the 
Wilcoxon test the results show that there 
are statistically significant differences in 
Copper content before and after in 
category 1 with a value of p = 0.005. In 
the category 2 group, there was a change 
in Cu levels before and after, ie a 
decrease of 31.66 ±7.35 μg / dL.Based on 
the analysis of the Wilcoxon test the 
results show that there are statistically 
significant differences in Cu levels before 
and after in category 2 with a value of p = 
0.005. Based on the non-parametric 
comparison test using the Mann-Whitney 
test, the results showed that there were 
statistically significant differences in 
Copper levels after between the category 
I and category II groups with a p value = 
0,000. In this study also obtained an 
average value of Cu levels after the use of 
ethambutol in the category I group of 
64.83 ± 5.39 μg / dL and in the category 
II group of 43.96 ± 5.94 μg / dL. Cu 
levels lower than 63.7 μg / dL are 
classified into Cu levels less than normal 
and Cu levels 63.7 μg / dL-140.12 μg / dL 
are classified as normal Cu levels. 
Copper contained in ethambutol 
interferes with oxidative phosphorylation, 
by not binding copper by mitochondria in 
the formation of ATP. This situation 
results in a change in the mitochondrial 
membrane potential, which then results in 
an increase in mitochondrial tissue 
fragmentation resulting in the formation 
of vacuoles in the mitochondria. 18,21-23 
The function of Cu in the eye plays a role 
in maintaining vision. The latest research 
conducted on the role of Cu in 
ethambutol toxicity found that Cu plays a 
role in ethambutol toxicity by triggering 
the occurrence of mitochondrial apoptosis 
in RGCs. 26-29 
In several studies conducted by 
Koyonagi et al, that in patients with 
pulmonary tuberculosis, serum Cu levels 
were obtained in patients using anti-
tuberculosis drugs significantly 
decreased.Abdonasser et al reported that 
after 10 days of Ethambutol treatment, the 
level of Cu in pulmonary tuberculosis 
patients decreased significantly. They 
also state that these results support the 
hypothesis that Etambutol with Cu can 
make complex chemical reactions in the 
body and cause changes in 
concentrationn.28-30 
In the category 1 group, there was an 
increase in the total error valuethrough 
FM100 examination before and after, 
which is 11.80±5.31. Based on the 
analysis of paired T test results obtained 
that there are statistically significant 
differences in the results of the FM100 
examination before and after in category 
1 with a value of p = 0,000. In the 
category 2 group, there was an increase in 
the total error value through FM100 
examination before and after, which was 
15.00±7.41. Based on the analysis of 
paired T test results obtained that there 
were statistically significant differences 
in the results of the FM100 examination 
before and after in category 2 with a 
value of p = 0,000. Based on the unpaired 
T test shows the results that there is a 
statistically significant difference in the 
results of the FM100 examination after 
between the category 1 and category 2 
groups with a value of p = 0,000. Polak et 
al reported that blue-yellow defects were 
the most common initial defects in 
Majalah Kedokteran Sriwijaya, 
Th. 52 Nomor 2, April 2020  
 291 
patients taking ethambutol therapy 
without symptoms of visual impairment. 
But the blue-yellow defect can only be 
detected using the Lantony desaturation 
panel or using Farnsworth Munsell 100 




Based on the research that has been 
done, it can be concluded that there is a 
significant comparison between FM100 
examination before and after the use of 
ethambutol in category I and 2 in lung 
patients and also obtained a significant 
comparison between Cu levels before and 
after the use of ethambutol in category I 
and II on pulmonary sufferers, so it can 
be concluded that the longer use of 
ethambutol can cause color vision 
disorders and a decrease in serum copper 
levels in the blood.This study found no 
significant correlation between the 
examination of Cu and FM100 Hue levels 
before and after the use of category I and 
category II ethambutol, this shows that 
the decrease in color vision was not only 
influenced by serum Cu levels but also 
influenced by several other factors.In 
addition to a color check with Ishihara, it 
is necessary to do a more sensitive 
examination with Farnsworth Munsell 
100 Hue to assess color vision disorders 
in patients with pulmonary tuberculosis 
who are given ethambutol therapy.It is 
necessary to evaluate copper levels in 
patients with pulmonary tuberculosis to 
prevent color vision problems.Provision 
of antioxidant supplements containing 
copper preparations in pulmonary TB 
patients receiving ethambutol can help 
reduce the effects of color vision 
changes.Need further research on 
pulmonary TB patients who use 
ethambutol for more than 6 months as in 
MDR TB patients to evaluate the 
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